Editors: Atta-ur-Rahman, M. Iqbal Choudhary

Frontiers in Anti-Cancer Drug Discovery

Volume 2

eBook: US $99 Special Offer (PDF + Printed Copy): US $176
Printed Copy: US $127
Library License: US $396
ISSN: 2451-8395 (Print)
ISSN: 1879-6656 (Online)
ISBN: 978-1-60805-809-9 (Print)
ISBN: 978-1-60805-808-2 (Online)
Year of Publication: 2013
DOI: 10.2174/97816080580821130201

Introduction

Frontiers in Anti-Cancer Drug Discovery is an Ebook series devoted to publishing the latest and the most important advances in Anti-Cancer drug design and discovery. Eminent scientists write contributions on all areas of rational drug design and drug discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships. The Ebook series should prove to be of interest to all pharmaceutical scientists involved in research in Anti-Cancer drug design and discovery. Each volume is devoted to the major advances in Anti-Cancer drug design and discovery. The Ebook series is essential reading to all scientists involved in drug design and discovery who wish to keep abreast of rapid and important developments in the field.

Indexed in: EMBASE, EBSCO, Ulrich's Periodicals Directory.

Contributors

Editor(s):
Prof. Atta-ur-Rahman
Honorary Life Fellow, Kings College
University of Cambridge
UK


Prof. M. Iqbal Choudhary
H.E.J. Research Institute of Chemistry
International Center for Chemical and Biological Sciences
University of Karachi
Pakistan




Contributor(s):
Priya Batra
Department of Biotechnology
Maharishi Markandeshwar University
Mullana-Ambala, 133203
India


Rajesh Naithani
Cancer Research Centre
Himalayan Institute and Hospital Trust
UK
India


Anil K. Sharma
Department of Biotechnology
Maharishi Markandeshwar University
Mullana-Ambala, 133203
India


Michael Luis
Department of Medical Oncology
Portuguese Oncology Institute
Rua Dr. António Bernardino de Almeida
Porto, 4200-072
Portugal


Ramon Andrade de Mello
Department of Medical Oncology
Portuguese Oncology Institute
Rua Dr. António Bernardino de Almeida
Porto, 4200-072
Portugal


Rohit Mathur
Department of Lymphoma/Myeloma
The University of Texas MD Anderson Cancer Center
Houston
Texas, 77030
USA


Anant N. Bhatt
Division of Radiation Biosciences
Institute of Nuclear Medicine and Allied Sciences
Delhi, 110054
India


Seema Gupta
Department of Radiation Oncology
University of Miami
Miami
Florida, 33136
USA


B.S. Dwarakanath
Division of Radiation Biosciences
Institute of Nuclear Medicine and Allied Sciences
Delhi, 110054
India


Sean M. Lawless
Center for Theoretical and Applied Neuro-Oncology
Moores Cancer Center, School of Medicine
University of California at San Diego
La Jolla
CA
USA


Johnny C. Akers
Center for Theoretical and Applied Neuro-Oncology
Moores Cancer Center, School of Medicine
University of California at San Diego
La Jolla
CA
USA


Chun-Lin Chen
Center for Theoretical and Applied Neuro-Oncology
Moores Cancer Center, School of Medicine
University of California at San Diego
La Jolla
CA
USA


Rui Liu
Department of Neurosurgery
Navy General Hospital of People's Liberation Army
Beijing, 100037
China


Bob Carter
Center for Theoretical and Applied Neuro-Oncology
Moores Cancer Center, School of Medicine
University of California at San Diego
La Jolla
CA
USA


Clark C. Chen
Center for Theoretical and Applied Neuro-Oncology
Moores Cancer Center, School of Medicine
University of California at San Diego
La Jolla
CA
USA


Georgi Ts. Momekov
Faculty of Pharmacy
Medical University-Sofia
2 Dunav Str.
Sofia, 1000
Bulgaria


Denitsa B. Momekova
Faculty of Pharmacy
Medical University-Sofia
2 Dunav Str.
Sofia, 1000
Bulgaria


Plamen T. Peykov
Faculty of Pharmacy
Medical University-Sofia
2 Dunav Str.
Sofia, 1000
Bulgaria


Nikolay G. Lambov
Faculty of Pharmacy
Medical University-Sofia
2 Dunav Str.
Sofia, 1000
Bulgaria


Mohammad F. Ullah
Department of Medical Laboratory Technology
Faculty of Applied Medical Sciences
University of Tabuk
Tabuk, 71491
KSA


Showket H. Bhat
Department of Medical Laboratory Technology
Faculty of Applied Medical Sciences
University of Tabuk
Tabuk, 71491
KSA


Eram Hussain
Department of Medical Laboratory Technology
Faculty of Applied Medical Sciences
University of Tabuk
Tabuk, 71491
KSA


Faisel Abu-Duhier
Department of Medical Laboratory Technology
Faculty of Applied Medical Sciences
University of Tabuk
Tabuk, 71491
KSA


Husain Y. Khan
Department of Biochemistry
Faculty of Life Sciences, AMU
Aligarh
(U.P.), 202002
India


Mohammad Aatif
Department of Biochemistry
Faculty of Life Sciences, AMU
Aligarh
(U.P.), 202002
India


Aamir Ahmad
Department of Pathology, Barbara Ann Karmanos Cancer Institute
Wayne State University School of Medicine
Hudson Webber Cancer Research Center
Detroit
MI, 48201
USA


S. M. Hadi
Department of Biochemistry
Faculty of Life Sciences, AMU
Aligarh
(U.P.), 202002
India


Milos Dokmanovic
Laboratory of Molecular Oncology, Division of Monoclonal Antibodies
Office of Biotechnology Products, Office of Pharmaceutical Science
Center for Drug Evaluation and Research, U.S. Food and Drug Administration
Bethesda
Maryland
USA


M. Khair ElZarrad
Laboratory of Molecular Oncology, Division of Monoclonal Antibodies
Office of Biotechnology Products, Office of Pharmaceutical Science
Center for Drug Evaluation and Research, U.S. Food and Drug Administration
Bethesda
Maryland
USA


Dianne S. Hirsch
Laboratory of Molecular Oncology, Division of Monoclonal Antibodies
Office of Biotechnology Products, Office of Pharmaceutical Science
Center for Drug Evaluation and Research, U.S. Food and Drug Administration
Bethesda, Maryland
USA


Wen Jin Wu
Laboratory of Molecular Oncology, Division of Monoclonal Antibodies
Office of Biotechnology Products, Office of Pharmaceutical Science
Center for Drug Evaluation and Research, U.S. Food and Drug Administration
Bethesda, Maryland
USA


Mireia Agirre
NanoBioCel Group
University of the Basque Country
Vitoria
Spain


Jon Zarate
NanoBioCel Group
University of the Basque Country
Vitoria
Spain


Gustavo Puras
NanoBioCel Group
University of the Basque Country
Vitoria
Spain


Luis Alfonso Rojas
Traslational Research laboratory
IDIBELL-Institut Català d´Oncologia
L´Hospitalet de Llobregat
Barcelona
Spain


Ramon Alemany
Traslational Research laboratory
IDIBELL-Institut Català d´Oncologia
L´Hospitalet de Llobregat
Barcelona
Spain


José Luis Pedraz
NanoBioCel Group
University of the Basque Country
Vitoria
Spain